Kristalijn, Syanni A.
White, Karen
Eerbeek, Deanna
Kostenko, Emilia
Grati, Francesca Romana
Bilardo, Caterina M.
Article History
Received: 7 February 2022
Accepted: 4 October 2022
First Online: 20 October 2022
Declarations
:
: All individuals completing the questionnaire were provided with a privacy statement and asked to indicate informed consent to the anonymous use of their responses as part of a research report. Interview participants gave permission verbally and provided a signed informed consent. The study protocol was reviewed by Medical Research Ethics Committees United (registration W21.048) and was determined not to fall within the scope of the Medical Research Involving Human Subjects Act (WMO).
: Not applicable.
: EK, SK, and KW are employees of Roche Diagnostics, a manufacturer of NIPT products. DE was a scholar at the VU University Amsterdam, completing a master’s internship at Roche Diagnostics. At the time of manuscript submission FRG was a full-time employee of TOMA laboratory without ownership shares and an expert panel member for Roche and consultant for Menarini Biomarkers/Silicon Biosystems. Now she is a full-time employee of Menarini Biomarkers Singapore. CMB is Emeritus Professor in Fetal Medicine at the Amsterdam UMC and did not receive any financial compensation from the sponsor.